Prosecution Insights
Last updated: July 17, 2026
Application No. 17/641,966

DRY POWDER INHALER FOR PULMONARY OR NASAL DELIVERY

Non-Final OA §112
Filed
Mar 10, 2022
Priority
Sep 27, 2019 — IT 102019000017417 +1 more
Examiner
STUART, COLIN W
Art Unit
3785
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Amiko S R L
OA Round
3 (Non-Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
509 granted / 874 resolved
-11.8% vs TC avg
Strong +55% interview lift
Without
With
+54.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
35 currently pending
Career history
906
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
67.9%
+27.9% vs TC avg
§102
1.9%
-38.1% vs TC avg
§112
8.5%
-31.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 874 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This office action is in response to the request for continued examination filed 6/8/26. Claims 1-2, 4-11, 13-15, and 17-22 are pending in the instant application. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-2, 4-11, 13-15, and 17-22 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "said inhaler" in line 7. There is insufficient antecedent basis for this limitation in the claim. Note that the claim sets forth a “dry powder inhaler” in line 1, but it is not clear if the language in line 7 is referring back to the same ‘dry powder inhaler’ or intending to set forth some other or additional inhaler. Claim limitation “electronic processing unit configured to receive signals …” (claim 1 line 14 and claim 22 line 18) invokes 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. However, the written description fails to disclose the corresponding structure, material, or acts for performing the entire claimed function and to clearly link the structure, material, or acts to the function. The disclosure, both the written specification and the drawings do not specify what structure is being referred to for performing the function of electronic processing of signals. The written specification just refers back to the generic placeholder in the same term/phrase and the drawings, in particular Fig. 12, which specifies the electronic processing unit as reference character “46”, do not provide any further clarity as to what structure is intended to perform the functional limitation as this figure is a schematic view. Therefore, the claim is indefinite and is rejected under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph. Applicant may: (a) Amend the claim so that the claim limitation will no longer be interpreted as a limitation under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph; (b) Amend the written description of the specification such that it expressly recites what structure, material, or acts perform the entire claimed function, without introducing any new matter (35 U.S.C. 132(a)); or (c) Amend the written description of the specification such that it clearly links the structure, material, or acts disclosed therein to the function recited in the claim, without introducing any new matter (35 U.S.C. 132(a)). If applicant is of the opinion that the written description of the specification already implicitly or inherently discloses the corresponding structure, material, or acts and clearly links them to the function so that one of ordinary skill in the art would recognize what structure, material, or acts perform the claimed function, applicant should clarify the record by either: (a) Amending the written description of the specification such that it expressly recites the corresponding structure, material, or acts for performing the claimed function and clearly links or associates the structure, material, or acts to the claimed function, without introducing any new matter (35 U.S.C. 132(a)); or (b) Stating on the record what the corresponding structure, material, or acts, which are implicitly or inherently set forth in the written description of the specification, perform the claimed function. For more information, see 37 CFR 1.75(d) and MPEP §§ 608.01(o) and 2181. Claims 2, 4-11, 13-15, and 17-21 are rejected based on dependency on a rejected claim. Allowable Subject Matter Claims 1-2, 4-11, 13-15, and 17-22 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. Reasons for Allowance The claims, as best understood in light of the above 112b rejections, appear to distinguish over the cited prior art references of record and the reasons set forth in the previous notice of allowability of 3/12/26 still apply. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to COLIN W STUART whose telephone number is (571)270-7490. The examiner can normally be reached M-F: 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Timothy Stanis can be reached at 571-272-5139. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /COLIN W STUART/Primary Examiner, Art Unit 3785
Read full office action

Prosecution Timeline

Show 8 earlier events
Jan 02, 2026
Examiner Interview Summary
Jan 12, 2026
Request for Continued Examination
Feb 13, 2026
Examiner Interview (Telephonic)
Feb 13, 2026
Response after Non-Final Action
Jun 08, 2026
Request for Continued Examination
Jun 11, 2026
Response after Non-Final Action
Jun 24, 2026
Non-Final Rejection mailed — §112
Jul 16, 2026
Interview Requested

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12654827
Buoy Snorkel
3y 9m to grant Granted Jun 16, 2026
Patent 12648888
REHABILITATION EXERCISE DEVICE FOR UPPER AND LOWER LIMBS
3y 3m to grant Granted Jun 09, 2026
Patent 12642935
A THERAPY SYSTEM FOR RESPIRATORY-RELATED DISORDERS, AND PATIENT INTERFACE AND HEADGEAR FOR USE IN SAME
4y 2m to grant Granted Jun 02, 2026
Patent 12630275
BREATHABLE MASK
3y 8m to grant Granted May 19, 2026
Patent 12623759
BREATHABLE MASK
3y 3m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+54.8%)
3y 8m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 874 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month